Abstract
Background: The long-term primary patency rates for percutaneous transluminal angioplasty using first and second generation stents for the treatment of the popliteal artery have been disappointing. However, results with the new nitinol stents seem promising. Our objective was to evaluate short-term clinical outcomes using the superflexible nitinol stent in the treatment of atherosclerotic lesions in popliteal segments. Methods: Retrospective longitudinal study conducted from April to December 2013. Population characteristics, procedure-related data and imaging tests were assessed at 6 months. Stent patency and limb salvage rates were obtained. Results: A total of 14 patients with mean age of 73 ± 11 years were included, of which 50% were male and 64.3% diabetic. All patients had trophic lesions in the treated limbs. The arteriographic lesions were classified according to the criteria of the Trans-Atlantic Inter-Society Consensus (TASC) criteria as TASC B and C inequal proportions. In the assessment of below-the-knee runoff, 78.6% of the patients had only one distal pervious artery, of which the fibular artery was the most frequently observed. The stent landing zone was the mid segment of the popliteal artery in 57.1% of the cases and the distal segment, crossing the knee joint, in the remaining patients. During the 6 month follow-up there were no stent fractures. The primary patency rate was 85.7% and the limb salvage rate was 100%. Conclusions: In our study, angioplasty using the super flexible nitinol stent demonstrated to be safe and effective for the treatment of atherosclerotic lesions of the popliteal artery.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have